72 results
Page 2 of 4
8-K
EX-99.1
2aprg6tw x84qmtl
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
8-K
EX-10.3
zqovh9uz dp3
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
nowqm5xs3qwwu7
14 Jan 22
Prospectus supplement
5:18pm
D
0489g3f
3 Jan 22
$8.32M in equity / options / securities to be acquired, sold $2.2M, 12 investors
5:16pm
8-K
EX-10.1
p4fwq
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
424B5
eusl9q84wyd65c
23 Dec 21
Prospectus supplement for primary offering
5:01pm
D
mfo8py
3 Dec 21
$12.82M in equity / options / securities to be acquired, sold $3.54M, 12 investors
4:16pm
8-K
EX-10.1
8k553d6s6vusqoes
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B5
3g4oepgrh
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
eoko0s820xrs zu
22 Nov 21
Definitive proxy
4:37pm
8-K
EX-99.1
d9mieo7m74mpktrr5
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
D
dlm1wk 29hlff4mhx6
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm
8-K
EX-10.1
dbscyb2p7
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
zehnrc1g8 kowk5f3s
15 Oct 21
Prospectus supplement for primary offering
5:01pm